Patients Stopping Slimming Jabs Put On Pounds Four Times Faster Compared to Dieters

Fresh analysis reveals that patients who stop using popular GLP-1 drugs like Wegovy and Mounjaro can put back on lost weight far faster than those who stop conventional lifestyle programs.

Research printed in a prominent medical journal demonstrates that while obese individuals often shed a large proportion of their total mass while on the medication, the weight comes back at an average rate of nearly a kilo each month upon discontinuation.

"Individuals purchasing such drugs should be informed of the danger of quick rebound weight gain when the therapy ends," stated expert Dr. Susan Jebb.

That rate of recovery means a return to original mass in about 18 months.

Comparing Approaches

The analysis, which examined 37 of studies involving thousands of patients, compared the effects of GLP-1 agonists with older methods.

The team point out that people who lose weight through diet and exercise usually see a slower creep back—perhaps 100 grams monthly—post-intervention.

Understanding the Fast Rebound

Nutrition scientists believe the way of the jabs explains the amplified regain.

These medications imitate a body's own chemical called GLP-1, which controls feelings of fullness.

"Long-term administration of the hormone levels far above than normal could lead to the body to generate a reduced amount of its endogenous hormone, and could diminish sensitivity to its effects," said Dr. Adam Collins, a dietetics expert.

"Stopping of this medication leads to hunger is unsuppressed, making overeating a significant risk."

A Lifelong Disease?

The NHS advise the injections for people with obesity-related health risks, accompanied by prescribed lifestyle changes.

Professionals say that, given the significant potential of relapse, the therapy might need to be life-long.

This perspective is echoed by pharmaceutical companies, who note that the results "underscore the long-term nature of excess weight," comparing it to managing conditions like diabetes.

User Testimonies

Users who have come off the jabs describe a powerful return of appetite.

"It was like something activating and you become starving," described one woman.

This challenge is worsened if patients have not established lasting lifestyle or habit modifications during treatment.

Significant Adoption

Recent estimates suggest that millions of people in the UK have used weight-loss jabs in the last 12 months, with desire continuing to grow.

• Use is more common among females than males.
• The middle-aged age group shows the greatest level of interest.
• Many obtain the medications through private healthcare rather than the NHS.

Ultimately, experts caution that while these medications are effective tools for shedding pounds, they are not a standalone solution and long-term success relies on ongoing lifestyle support.